Hospices Civils de Lyon - Hôpital Henry Gabrielle & Hôpital Neurologique
Saint-Genis-Laval, 69230, France
NCT Number: NCT02759068
Preferred music improves cognitive function in patients with disorders of consciousness (DOC). However, it is still unknown whether it is a general effect of music (because of its acoustic features) or an autobiographical effect (because of its emotional and meaningful contents).
The aim of the present study was to investigate the effect of sensory modality (auditory versus olfactory) and preference (preferred versus neutral) of the testing context on the performance of four items from the coma recovery scale-revised
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Saint-Genis-Laval, 69230, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
presentation of sounds and odors
Time frame: within the first 30 days
Improvement of the score following sound stimuli and/or preferred stimuli
Time frame: within the first 30 days
Faster reaction following sound stimuli and/or preferred stimuli
Hospices Civils de Lyon
Other
Beneficial Effects of Preference on Behavior
Acronym: COGNICOMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06693492
Brain Damage, Chronic, Brain Diseases
Crotone, Calabria, Italy
View Trial DetailsNCT04330547
Brain Damage, Chronic, Brain Diseases
Liège, Belgium
View Trial DetailsNCT02626403
Brain Damage, Chronic, Brain Diseases
Liège, Belgium
View Trial DetailsNCT02930213
Brain Damage, Chronic, Brain Diseases
View Trial Details